Mangoceuticals, Inc.
MGRX • NASDAQ
Mangoceuticals, Inc. is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Jacob D. Cohen, with a market cap of $7.9M.
CEOJacob D. Cohen
Next Earnings
Upcoming earnings announcement for Mangoceuticals, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for Mangoceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Q4 2025 | -$0.13 | — | $94.4K | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.69 | — | $84.2K | — | 10-Q/A |
| Aug 14, 2025 | Q2 2025 | -$0.57 | — | $168.1K | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$1.29 | — | $109.3K | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$1.01 | — | $105.2K | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.99 | — | $133.4K | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$1.35 | — | $163.2K | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$1.50 | — | $214.1K | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$1.80 | — | $244.4K | — | — |
| Oct 27, 2023 | Q3 2023 | -$1.65 | — | $245.2K | — | 10-Q |
| Jul 28, 2023 | Q2 2023 | -$2.10 | — | $141.2K | — | — |